Baxter International stock steadies near recent lows as analysts stick with Hold ratings

Baxter International Inc. stock (ISIN US0673431090) closed at USD 23.51 on the New York Stock Exchange on September 16, 2026, slipping 0.84 percent from the previous session as investors continued to weigh the company’s recovery prospects in the medical products sector according to MarketBeat data cited in a recent overview on September 18, 2026.

Analyst targets signal cautious outlook

According to MarketBeat on September 18, 2026, Baxter International stock currently carries an average analyst rating of Hold, with a consensus price target of USD 22.45, indicating that most covering analysts see limited upside from the latest closing level of USD 23.51.

This implies that the consensus target stands about 4.5 percent below the September 16, 2026, closing price, underlining that the market expects the shares to trade sideways or slightly lower rather than pricing in a strong near-term rally based on existing earnings and guidance assessments.

Recent trading range and volatility

Per a corporate news overview dated September 18, 2026, Baxter International stock (NYSE: BAX) traded between an intraday low of about USD 23.32 and a high near USD 23.89 on September 16, 2026, with the close of USD 23.51 sitting toward the middle of that range according to NYSE data referenced by Ad hoc news.

The 0.84 percent decline on September 16, 2026, represented a move of USD 0.20 against the prior close, a relatively modest drop that nevertheless keeps the shares near the lower end of their performance over the past year as investors monitor margins, product mix and potential regulatory risks for global medical-technology suppliers.

Stock performance over the past year

According to the Baxter International Inc. page on TradingView accessed on September 18, 2026, the current price of Baxter International stock is around USD 23.10, and the shares have fallen approximately 36.89 percent over the last twelve months, illustrating the magnitude of the longer-term drawdown that investors in the company have absorbed.

The same TradingView overview notes that Baxter International stock has gained about 0.39 percent compared with the previous week and roughly 1.28 percent over the past month, suggesting that while the long-term trend remains negative, shorter-term trading has stabilized somewhat as the market digests cost-cutting, portfolio adjustments and balance-sheet measures implemented after earlier strategic reviews.

Dividend yield and income profile

TradingView data as of September 18, 2026, also shows that Baxter International’s trailing twelve-month dividend yield stands at about 2.95 percent, indicating that the company continues to return cash to shareholders despite the pressure on the share price over the past year.

For income-focused investors, this yield provides a modest compensation for the share-price volatility, but the roughly 36.89 percent decline in the stock over the last twelve months means that total return has been clearly negative, and the sustainability of the dividend will remain tied to the company’s ability to stabilize earnings and cash flow in its latest quarterly and fiscal-year results.

Investor takeaways from current levels

Putting these metrics together, Baxter International stock now trades close to USD 23.10 on the NYSE as of September 18, 2026, compared with the consensus price target of USD 22.45 from MarketBeat, which signals that the market price already sits slightly above what analysts consider fair value based on their latest models and expectations.

The combination of a 2.95 percent trailing dividend yield, a roughly 36.89 percent share-price decline over the past twelve months and a Hold-rating consensus suggests that many professional observers see Baxter International as a value-contender with meaningful execution risks rather than a clear growth story, making upcoming quarterly results and any updated guidance crucial checkpoints for reassessing the risk-reward profile.

Baxter International stock price snapshot

As of September 18, 2026, Baxter International stock is quoted around USD 23.10 on the NYSE, with the previous closing price of USD 23.51 on September 16, 2026, marking a 0.84 percent daily decline that keeps the shares trading near their recent lows and well below levels seen a year ago.

More news and analyses on Baxter International stock